论文部分内容阅读
应用放射性核素作为示踪剂来研究心血管的形态和功能,是七十年代心血管病诊断技术的一项进展。放射性核素在心血管病诊断上的应用,开始于Rajali(1958)用碘—人血清白蛋白(I—HAS)静注进行心脏血池扫描诊断心包积液。六十年代以后,由于r闪烁照相机的发明和改进,以及电子计算机的配合,为心血管核医学开辟的广阔的前景。我国自72年以来,同位素在心血管病的临床应用也有了很大的进展。利用放射性核素进行心脏动态功能检查(心血管r照相,心脏血池扫描,核听诊器)和静态心肌显影(心肌扫描—心肌梗塞闪烁图和心肌灌注闪烁图),临床上已用于诊断常见先天性心脏病及部分获得性心脏病
The use of radionuclides as a tracer to study cardiovascular morphology and function is an advance in the diagnostic techniques for cardiovascular disease in the 1970s. The application of radionuclides in the diagnosis of cardiovascular disease began with the Rajali (1958) cardioplegia scan with Iodine-Human Serum Albumin (I-HAS) intravenous injection to diagnose pericardial effusion. Since the 1960s, due to the invention and improvement of the r-blinking camera and the cooperation of electronic computers, it has opened up a broad prospect for cardiovascular nuclear medicine. Since 72 years in China, isotopes have also made great progress in the clinical application of cardiovascular diseases. Radiological radionuclide cardiac dynamic function tests (cardiovascular r photography, cardiac blood pool scan, nuclear stethoscope) and static myocardial imaging (myocardial scan-myocardial infarction scintigraphy and myocardial perfusion scintigraphy) has been clinically used to diagnose common Innate Sexual and partial acquired heart disease